Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. Its products treat psychiatric and neurological conditions including Attention Deficit/Hyperactivity Disorder (ADHD), epilepsy, Parkinson’s disease (PD), migraine, etc. The company also develops products including for the treatment of ADHD in adults, an apomorphine infusion pump for hypomobility in PD, and a solution for treatment-resistant depression.